Fasudil (WP-0512) ( DrugBank: Fasudil )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05218668 (ClinicalTrials.gov)	December 22, 2021	23/11/2021	Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)	A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients With ...	Amyotrophic Lateral Sclerosis	Drug: Fasudil (WP-0512)	Woolsey Pharmaceuticals	NULL	Active, not recruiting	18 Years	75 Years	All	30	Phase 2	United States;Australia

First Previous1Next Last